Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40.204
Filter
1.
Arch. argent. pediatr ; 120(6): S88-S94, dic. 2022. tab
Article in Spanish | LILACS, BINACIS | ID: biblio-1399917

ABSTRACT

La tasa de prematuridad global, según laOrganización Mundial de la Salud (OMS),muestra un aumento progresivo; su principal componente es el grupo de prematuros tardíos. Este grupo de pacientes suele tener buen peso al nacer, lo que hace que no se perciba muchas veces el riesgo de presentar un espectro de morbilidades del desarrollo, conductuales einmadurez de diferentes órganos y sistemasque impactan en la evolución a corto y largo plazo y aumentan la morbimortalidad. A su vez, tienen un efecto sustancial en los servicios de atención médica. El objetivo de esta publicación es discutir algunosaspectos relacionados con la salud de este grupo de pacientes y sugerir su seguimiento con un enfoque holístico e interdisciplinario.


The WHO states that prematurity rates have increased mainly due to late preterm births. Since these babies are usually born with appropriate weight for their gestational age, their risk for morbidities such as neurodevelopmental delays, behavioral problems and organ systems immaturity are overlooked. Further, these clinical findings have an impact on short and long term outcomes (i.e., morbidities, mortality, and higher healthcare costs). The aim of this publication is to discuss topics related to late-preterm newborns' health, including a holistic and interdisciplinary approach to follow up care.


Subject(s)
Humans , Infant, Newborn , Infant , Premature Birth , Infant, Premature, Diseases/diagnosis , Infant, Premature, Diseases/therapy , Infant, Low Birth Weight , Follow-Up Studies , Gestational Age
2.
Article in Spanish | LILACS, BNUY, UY-BNMED | ID: biblio-1403140

ABSTRACT

El método de Ilizarov, con sus diferentes variantes y mediante la utilización de su aparato, desarrollado en la década del 50, continúa vigente, sobre todo en el tratamiento de las complicaciones de fracturas, principalmente aquellas vinculadas a la infección y a las dificultades de la consolidación. Reportamos 2 pacientes adultos con diagnóstico de pseudoartrosis hipertrófica, rígida, con deformidad, sin infección activa y sin dismetría, tratados mediante el método de distracción y compresión realizado con el aparato de Ilizarov. En ambos casos se logró la alineación y consolidación del miembro con escasas complicaciones.


The Ilizarov method, with its different variants and using its apparatus, developed in the 1950s, is still valid, especially in the treatment of fracture complications, mainly those linked to infection and consolidation difficulties. We report 2 adult patients with a diagnosis of hypertrophic, rigid nonunion, with deformity, without active infection and without dysmetria, treated by the distraction and compression method performed with the Ilizarov device. In both cases, the alignment and consolidation of the limb was achieved with few complications.


O método de Ilizarov, com suas diferentes variantes e pelo uso de seu aparato, desenvolvido na década de 1950, ainda é válido, principalmente no tratamento de complicações de fraturas, principalmente aquelas ligadas à infecção e dificuldades de consolidação. Relatamos 2 pacientes adultos com diagnóstico de pseudoartrose hipertrófica, rígida, com deformidade, sem infecção ativa e sem dismetria, tratados pelo método de distração e compressão realizado com o dispositivo de Ilizarov. Em ambos os casos, o alinhamento e a consolidação do membro foram alcançados com poucas complicações.


Subject(s)
Humans , Male , Adult , Middle Aged , Pseudarthrosis/surgery , Tibial Fractures/surgery , Ilizarov Technique , Postoperative Period , Tibial Fractures/complications , Follow-Up Studies , Treatment Outcome , Intraoperative Period
3.
Arch. pediatr. Urug ; 93(1): e203, jun. 2022. tab, graf
Article in Spanish | LILACS, BNUY, UY-BNMED | ID: biblio-1383640

ABSTRACT

Introducción: en Uruguay, la proporción de nacimientos con bajo peso al nacer (BPN) se mantiene cercana al 8%. En este grupo resulta un desafío conseguir un adecuado crecimiento y desarrollo enfocado a prevenir enfermedades a mediano y largo plazo. Objetivo: analizar la velocidad de crecimiento y los aspectos nutricionales de una cohorte de recién nacidos (RN) con BPN desde su egreso hospitalario y hasta los 12 meses de edad corregida (EC). Metodología: estudio descriptivo, prospectivo, de los RN con BPN de la unidad neonatal de la Maternidad del Hospital de Clínicas Dr. Manuel Quintela, entre el 1 de enero y el 31 de diciembre de 2015. Se excluyeron los portadores de malformaciones congénitas y patología quirúrgica al nacer. Se evaluó peso, longitud y perímetro craneano al egreso, y a los 5, 9 y 12 meses de EC. La velocidad del crecimiento fue analizada mediante z-score y Δz-score ajustado a EC en curvas de la OMS. Se estimó aporte nutricional en cada control y se exploraron asociaciones entre cambios en la curva de crecimiento y el grado de adecuación de la ingesta calórica estimada. Resultados: ingresaron al estudio 31 recién nacidos: con peso al nacer <1.500 g hubo 7 neonatos y ≥1.500 g 24. Edad gestacional (EG) media 32,5 semanas (rango 25-39), un término y 30 prematuros: extremos 2, muy prematuros 9, y moderados 19. En relación al peso al nacer para la EG 21 fueron adecuados (AEG), 7 pequeños (PEG) y 3 grandes (GEG). Completaron los tres controles programados 26 niños. En el primer control mantuvieron el carril de crecimiento 15 niños, descendieron 8 y aceleraron 8; en el segundo mantuvieron 9, desaceleraron 8 y aceleraron 12; y en el tercero mantuvieron 9, desaceleraron 7 y aceleraron 10. El número de niños que al final del seguimiento mantenían el mismo carril de crecimiento que al nacer, descendió a expensas de un aumento de aquellos que aceleraron el crecimiento. Al llegar al tercer control se encontró que sólo 9 niños mantuvieron el carril de crecimiento al nacer y el resto (17) cambiaron de carril, lo cual resultó en una diferencia significativa. En los 10 pacientes que aceleraron su crecimiento durante el primer año de vida, no se encontraron asociaciones entre la velocidad de crecimiento y las características energéticas de la alimentación complementaria que recibían. Conclusiones: se observaron problemas en el crecimiento de los niños con BPN durante el primer año de vida. Una proporción significativa presentaron crecimiento acelerado lo cual es un factor de riesgo para obesidad y enfermedades crónicas no transmisibles. Es necesario profundizar en las causas de estas alteraciones, en especial relacionadas con las prácticas de alimentación, para desarrollar estrategias que contribuyan a la prevención.


Introduction: in Uruguay, the proportion of low weight births (LBW) remains close to 8%. It is a challenge to achieve adequate growth and development focused on preventing diseases in the medium and long term for the case of this group. Objective: analyze the growth rate and nutritional aspects of a cohort of newborns (NB) with LBW since they were discharged from the hospital and until 12 months of corrected age (CA). Methodology: descriptive, prospective study of NBs with LBW of the neonatal ward of the Manuel Quintela Maternity Hospital, between January 1 and December 31, 2015. We excluded carriers of congenital malformations and surgical pathology at birth and assessed weight, length and cranial perimeter at discharge, and at 5, 9 and 12 months of CA. The growth rate was analyzed using z-score and Δz-score adjusted to CA in WHO curves. Nutritional contribution was estimated in each check-up and associations were explored between changes in the growth curve and the degree of adequacy of the estimated caloric intake. Results: 31 newborns participated in the test: 7 newborns had a birth weight of <1.500 g and ≥1.500 g: 24. Mean Gestational Age (GA) 32.5 weeks (range 25-39), one term and 30 preterm newborns: extreme 2, very premature 9, and moderate 19. Regarding birth weight according to gestational age, 21 were appropiate for gestational age (AGA), 7 small for gestational age (SGA) and 3 large for gestational age (LGA). The 26 children completed the 3 scheduled check-ups. In the 1st check-up, 15 children had been able to maintain the growth trend, in 8 of them it had decreased and in 8 it had accelerated; in the 2nd check-up 9 of them maintained their growth rate, 9 decreased it and 12 of the newborns increased it; and in the 3rd check-up, the trend remained steady for 9 of them , it decreased for 7 of them and it increased for 10 of them. The number of children who at the end of the follow-up maintained the same growth trend they had at birth decreased, despite the increase in the growth trend of those with a more accelerated growth. At the time of the 3rd check-up it was found that only 9 children maintained the growth trend they had at birth and the rest, (17), changed trends, which resulted in a significant gap. We did not find links life between the growth rate and the energy characteristics of the supplementary food they received in the 10 patients who had increased their growth rate in their first year of life. Conclusions: we observed problems regarding the growth rate of children with LBW during the first year of life. A significant proportion showed accelerated growth, which is a risk factor for obesity and chronic non-communicable diseases. It is necessary to research the causes of these alterations, especially regarding their feeding practices in order to develop strategies for their prevention.


Introdução: no Uruguai, a proporção de recém-nascidos com baixo peso ao nascer (LBW) permanece próxima de 8%. É um desafio alcançar um crescimento e desenvolvimento adequados focados na prevenção de doenças a médio e longo prazo nesse grupo de crianças. Objetivo: analisar a taxa de crescimento e aspectos nutricionais de uma coorte de recém-nascidos (RN) com LBW no momento da alta hospitalar e até 12 meses de idade corrigida (EC). Metodologia: estudo prospectivo de RNs com LBW da unidade neonatal da Maternidade do Hospital Dr. Manuel Quintela, entre 1º de janeiro e 31 de dezembro de 2015. Foram excluídos portadores de malformações congênitas e patologia cirúrgica ao nascer. Peso, comprimento e perímetro craniano foram avaliados no momento da alta hospitalar e aos 5, 9 e 12 meses de EC. A velocidade de crescimento foi analisada utilizando-se pontuação z e pontuação Δz ajustada ao EC das curvas da OMS. A contribuição nutricional foi estimada em cada controle e as associações entre mudanças na curva de crescimento e o grau de adequação da ingestão calórica estimada foram exploradas. Resultados: 31 recém-nascidos entraram no estudo: com peso ao nascer <1500 g havia 7 recém-nascidos e ≥1500 g: 24. Idade Gestacional Média (EG) 32,5 semanas (faixa 25-39), um termo e 30 prematuros: extremos 2, muito prematuros 9 e moderados 19. Em relação ao peso ao nascer para EG, 21 foram adequados (AEG), 7 pequenos (PEG) e 3 grandes (GEG). As 26 crianças completaram os 3 controles programados. No 1º controle, 15 crianças mantiveram a faixa de crescimento, 8 desceram e 8 aceleraram; no 2º mantiveram 9, desaceleraram 8 e aceleraram 12; e no 3º mantiveram 9, desaceleraram 7 e aceleraram 10. O número de crianças que, ao final do seguimento, manteve a mesma faixa de crescimento do que ao nascer diminuiu mesmo que houve um aumento daqueles que aceleraram o crescimento. No 3º controle foi constatado que apenas 9 crianças mantiveram a faixa de crescimento que tinham ao nascer e o resto (17) mudou de faixa, resultando numa diferença significativa. Nos 10 pacientes que aceleraram seu crescimento durante o primeiro ano de vida, não foram encontradas associações entre a velocidade de crescimento e as características energéticas da alimentação complementar que receberam. Conclusões: foram observados problemas no crescimento de crianças com LBW durante o primeiro ano de vida. Uma proporção significativa delas mostrou crescimento acelerado, que é um fator de risco para obesidade e doenças crônicas não transmissíveis. É necessário aprofundar nas causas dessas alterações, especialmente aquelas relacionadas às práticas alimentares para poder desenvolver estratégias que contribuam para a prevenção.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Body Weight , Energy Intake , Infant, Low Birth Weight/growth & development , Socioeconomic Factors , Prospective Studies , Follow-Up Studies , Longitudinal Studies
5.
Int. j. morphol ; 40(3): 608-612, jun. 2022. ilus, tab
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1385644

ABSTRACT

RESUMEN: La endometriosis (E), se define como presencia de glándulas endometriales y estroma fuera del útero. Ocasionalmente se presenta como masa sensible en la pared abdominal (PA), en relación con una cicatriz quirúrgica (EPA). Aunque el tratamiento es quirúrgico, existe poca información respecto de la morbilidad postoperatoria (MPO) y la recurrencia de la EPA. El objetivo de este estudio fue determinar MPO y recurrencia en pacientes resecadas quirúrgicamente por EPA. Serie de casos de pacientes con EPA, sometidos a cirugía de forma consecutiva, en Clínica RedSalud Mayor, entre 2011 y 2021. Las variables resultados MPO y recurrencia. Otras variables de interés fueron: tiempo quirúrgico, estancia hospitalaria y mortalidad. Las pacientes fueron seguidas de forma clínica. Se utilizó estadística descriptiva, con medidas de tendencia central y dispersión. Se intervinieron 14 pacientes, con una mediana de edad de 33 años. La medianas del tiempo quirúrgico y estancia hospitalaria; fueron 55 min y 2,5 días respectivamente. La MPO fue 14,2 % (2 casos). Con una mediana de seguimiento de 31 meses, no se verificó recurrencia. Aunque la EPA es poco común, estas lesiones deben sospecharse en mujeres en edad reproductiva con masa palpable en relación con una cicatriz de cirugía ginecológica u obstétrica. Los resultados obtenidos, en términos de MPO y recurrencia, fueron similares a series internacionales.


SUMMARY: Endometriosis (E) is defined as the presence of endometrial glands and endometrial stroma outside the uterus. Occasionally it presents as a sensitive mass in the abdominal wall (AW), in relation to a surgical scar (AWE). Although the treatment is surgical, there is scarce information regarding postoperative morbidity (POM) and recurrence of AWE. The aim of this study was to determine POM and recurrence in patients surgically resected by AWE. Case series of patients with AWE, consecutively submitted to surgery, at RedSalud Mayor Clinic, between 2011 and 2021. Outcome variables were POM and recurrence. Other variables of interest were surgical time, hospital stay and mortality. Patients were followed-up clinically. Descriptive statistics were used, applying central tendency and dispersion measures. 14 patients were intervened, with a median age of 33 years. Median of surgical time and hospital stay were 55 min and 2,5 days respectively. POM was 14.2 % (2 cases). With a median follow-up of 31 months no recurrence was verified. Although AWE is uncommon, these lesions should be suspected in women in fertile age with a palpable mass associated with a scar from gynecologic or obstetric surgery. The results obtained, in terms of POM and recurrence, were like international series.


Subject(s)
Humans , Female , Pregnancy , Adult , Cesarean Section/adverse effects , Cicatrix/etiology , Endometriosis/surgery , Postoperative Complications , Recurrence , Retrospective Studies , Follow-Up Studies , Abdominal Wall/surgery
6.
Int. j. morphol ; 40(3): 855-859, jun. 2022. ilus, tab
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1385666

ABSTRACT

RESUMEN: Gran parte de los pacientes con cáncer de colon (CC), son diagnosticados y tratados de forma electiva. Sin embargo, aproximadamente un 20 % de ellos debutará como una emergencia (obstrucción o perforación). El objetivo de este estudio fue determinar morbilidad postoperatoria (MPO) y supervivencia global (SVG) en pacientes resecados por CC perforado (CCP). Serie de casos retrospectiva de pacientes con CCP, sometidos a colectomía y linfadenectomía, de forma consecutiva, en Clínica RedSalud Mayor y Hospital de Temuco, Chile, entre 2010 y 2019. Las variables resultados fueron SVG y MPO. Otras variables de interés fueron: tiempo quirúrgico, resecabilidad, número de linfonodos resecados, estancia hospitalaria, mortalidad operatoria, recurrencia y supervivencia libre de enfermedad (SLE). Los pacientes fueron seguidos de forma clínica. Se utilizó estadística descriptiva, con medidas de tendencia central y dispersión; y análisis de SV con curvas de Kaplan Meier. Se intervinieron 15 pacientes (60 % mujeres), con una mediana de edad de 62 años. La localización más frecuente fue sigmoides (6 casos; 40,0 %). La resecabilidad de la serie fue 100 %. La medianas del tiempo quirúrgico, número de linfonodos resecados y estancia hospitalaria; fueron 80 min, 20 y 5 días respectivamente. La MPO fue 26,7 % (4 casos). Con una mediana de seguimiento de 36 meses, se verificó una recurrencia de 40,0 %. Por otra parte, la SVG y SLE a 5 años fue 46,7 % y 33,3 % respectivamente. Los resultados obtenidos, en términos de MPO y SVG, fueron similares a series internacionales.


SUMMARY: Most patients with colon cancer (CC) are diagnosed and treated electively. However, a fifth of them will debut as an emergency (obstruction or perforation). The aim of this study was to determine postoperative morbidity (POM) and overall survival (OS) in patients resected by perforated CC (PCC). Retrospective case series of patients with PCC undergoing colectomy and lymphadenectomy, consecutively, at RedSalud Mayor Clinic and Temuco hospital, Chile, between 2010 and 2019. The outcome variable were POM and OS. Other variables of interest were surgical time, resectability, number of resected lymph nodes, hospital stay, mortality, recurrence, and disease-free survival (DFS). Patients were followed clinically. Descriptive statistics was used (measures of central tendency and dispersion), and OS analysis was applying Kaplan Meier curves.15 patients (60 % women) were intervened, with a median age of 62 years. The most frequent location was the sigmoid colon (6 cases, 40.0 %). Resectability of the series was 100 %. Median surgical time, number of lymph nodes resected, and hospital stay; they were 80 min, 20 and 5 days respectively. POM was 26.7 % (4 cases). With a median follow-up of 36 months, recurrence was 40.0 %. On the other hand, OS and DFS at 5 years were 46.7 % and 33.3 %, respectively. The observed results, in terms of POM and OS, were like international series.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Colectomy , Colonic Neoplasms/surgery , Colonic Neoplasms/complications , Intestinal Perforation/etiology , Postoperative Complications , Colon, Sigmoid , Survival Analysis , Retrospective Studies , Follow-Up Studies , Emergencies , Lymph Node Excision , Neoplasm Recurrence, Local
7.
Rev. bras. ortop ; 57(3): 472-479, May-June 2022. tab
Article in English | LILACS | ID: biblio-1388009

ABSTRACT

Abstract Objective To evaluate the patients submitted to arthroscopic repair of the rotator cuff (RC), comparing the functional results, muscle strength, and pain obtained after single row (SR) and double row (DR) techniques. Methods Data were collected at the postoperative follow-up (minimum of 12 months) of 128 patients submitted to arthroscopic RC repair from 2011 to 2018. The clinical-functional variables were collected through the clinical examination, and the demographic, surgical and injury variables of the RC were collected from the electronic medical records. The results were compared between the SR and DR groups. Results The DR group showed higher anterior elevation strength when compared with the SR group (SF: 4.72 ± 2.73 kg versus DR: 5.90 ± 2.73 kg; p = 0.017). The other variables of muscle strength, Constant-Murley Score, University of California at Los Angeles Shoulder Rating Scale (UCLA), and pain, were similar. Performing the stratification by size, in the analysis of small and medium injuries, no differences were found between the groups. However, in the analysis of large and extensive injuries, patients submitted to DR presented superiority of both muscle lifting strength (SF: 3.98 ± 2.24 kg versus DR: 6.39 ± 2.73 kg) and Constant score (SF: 81 ± 10 versus DR: 88 ± 7). Conclusion The use of the DR technique in arthroscopic RC repair allowed higher levels of muscle strength for anterior shoulder elevation when compared with the SF technique. Data stratification in large and extensive injuries showed superiority of anterior shoulder elevation muscle strength and of the Constant score in patients submitted to DR.


Resumo Objetivo Avaliar os pacientes submetidos ao reparo artroscópico do manguito rotador (MR), comparando-se os resultados funcionais, força muscular e dor obtidos após as técnicas de fileira simples (FS) e de fileira dupla (FD). Métodos Foram coletados os dados do seguimento pós-operatório (mínimo de 12 meses) de 128 pacientes submetidos ao reparo artroscópico do MR durante o período de 2011 a 2018. As variáveis clínico-funcionais foram coletadas por meio do exame clínico, e as variáveis demográficas, cirúrgicas e das lesões do MR a partir dos prontuários eletrônicos. Os resultados foram comparados entre os grupos FS e FD. Resultados O grupo FD demonstrou força de elevação anterior maior quando comparado ao grupo FS (FS: 4,72 ± 2,73 kg versus FD:5,90 ± 2,73 kg; p = 0,017). As demais variáveis de força muscular, Constant-Murley Score, University of California at Los Angeles Shoulder Rating Scale (UCLA, na sigla em inglês) e dor foram similares. Realizando-se a estratificação por tamanho, na análise das lesões pequenas e médias, não foram encontradas diferenças entre os grupos. Porém, na análise das lesões grandes e extensas, os pacientes submetidos à FD apresentaram superioridade tanto na força muscular de elevação (FS: 3,98 ± 2,24 kg versus FD: 6,39 ± 2,73 kg) quanto no escore Constant (FS: 81 ± 10 versus FD: 88 ± 7). Conclusão A utilização da técnica de FD no reparo artroscópico do MR possibilitou maiores níveis de força muscular para elevação anterior do ombro quando comparada à técnica de FS. A estratificação dos dados em lesões grandes e extensas evidenciou superioridade da força muscular de elevação anterior do ombro e do escore Constant nos pacientes submetidos à FD.


Subject(s)
Humans , Male , Female , Arthroscopy , Follow-Up Studies , Muscle Strength , Rotator Cuff Injuries
8.
Cienc. Salud (St. Domingo) ; 6(2): 95-102, 20220520. ilus
Article in Spanish | LILACS | ID: biblio-1379469

ABSTRACT

El síndrome de Kocher Debré Semelaigne (SKDS) se describe dentro de las formas clínicas atípicas asociadas al hipotiroidismo congénito (HC) severo, no tratado y de larga evolución, con manifestaciones de pseudohipertrofia muscular difusa y debilidad muscular predominantemente proximal, reversible al reemplazo con tiroxina. Es raro en países con programas de pesquisa neonatal. Objetivo: reportar el caso de un niño con diagnóstico de HC por disembriogenesis (atireosis), que se mantuvo con mal control de la enfermedad durante el primer año de vida y manifestaciones miopáticas desde la etapa neonatal. Resultados: se confirma el diagnóstico a través de estudios específicos, con evidencias de patrones miopáticos característicos. Se logra regresión clínica parcial a los nueve meses de mantener estabilidad de la TSH y las hormonas tiroideas (HT), coincidiendo con la normalización de la enzima de músculo creatinfosfoquinasa (CPK). A los 12 años de seguimiento, mantenía ligera hipertrofia de la musculatura de las extremidades superiores, dorsales y glúteos, a pesar de mantenerse eutiroideo. Conclusiones: la presencia de hipertrofia muscular debe considerarse un dato clínico de sospecha de hipotiroidismo, aun con la implementación de los programas de pesquisa neonatal. Es posible la regresión parcial de la pseudohipertrofia muscular con el restablecimiento de la función tiroidea. Se debe tomar en cuenta en el diagnóstico diferencial de otras miopatías primarias


Kocher-Debré-Semelaigne Syndrome (SKDS) is described within the atypical clinical forms associated with severe, untreated and long-standing congenital hypothyroidism with manifestations of diffuse muscle pseudohypertrophy and predominantly proximal muscle weakness, reversible to replacement with levothyroxine. objective: To report the case of a child with congenital hypothyroidism due to disembriogenesis (atyreosis), who remained with poor control of the disease during the 1st year of life and myopathic manifestations from de neonatal stage. Results: The diagnosis is confirmed through specific studies, with evidence of characteristic myopathic patterns. Partial clinical regression is achieved 9 months after maintaining stability of TSH and thyroid hormones, coinciding with the normalization of the muscle enzyme creatine phosphokinase (CPK). At 12 years of follow-up, he maintained slight hypertrophy of the muscle of the upper extremities, dorsal and buttocks, despite remaining euthyroid. Conclusions: The presence of muscular hypertrophy should be considered a clinical finding of suspected hypothyroidism, even with the implementation of neonatal screening programs. Partial regression of muscle pseudohypertrophy is possible with restoration of thyroid function, and should be taken into account in the differential diagnosis of other primary myopathies


Subject(s)
Humans , Male , Infant , Congenital Hypothyroidism/complications , Muscular Diseases/etiology , Thyroxine/administration & dosage , Follow-Up Studies , Congenital Hypothyroidism/diagnosis , Congenital Hypothyroidism/drug therapy , Skeletal Muscle Enlargement
9.
Rev. Ciênc. Méd. Biol. (Impr.) ; 21(1): 46-52, maio 05,2022. fig, tab
Article in Portuguese | LILACS | ID: biblio-1370569

ABSTRACT

Introdução: a avaliação e intervenção motora possibilitam minimizar os atrasos no desenvolvimento motor de crianças prematuras. Objetivo: o objetivo deste estudo foi avaliar o desenvolvimento motor de crianças prematuras, de 0 a 12 meses de idade corrigida, após intervenção baseada em orientações aos pais. Metodologia: a amostra foi composta por 43 bebês nascidos prematuros e para avaliação do desempenho motor foi utilizada a Alberta Infant Motor Scale (AIMS), além de dois questionários qualitativos para identificação e controle dos fatores de risco. Foi utilizada estatística descritiva e os testes de Wilcoxon e McNemar para analisar as mudanças ao longo do tempo (p < 0,05). Resultados: através do follow-up, após as orientações aos pais, o número de bebês que apresentavam desempenho motor abaixo do esperado foi reduzido. Os percentis obtidos no desempenho motor nos dois momentos avaliativos indicam que houve melhora ao longo do tempo (p = 0,05), assim como os dados referentes à categorização (p = 0,04). Conclusões: é importante o acompanhamento e identificação da influência dos fatores de risco sobre os bebês para que medidas interventivas possam ser implementadas precocemente, sendo o modelo baseado em orientações um método de baixo custo e de fácil aplicabilidade em serviços públicos de saúde.


AbstractIntroduction: motor assessment and intervention makes it possible to minimize delays in motor development of premature children. Objective: the aim of this study was to evaluate the motor development of premature children, from 0 to 12 months of corrected age, after an intervention based on guidance to parents. Methodology: The sample consisted of 43 babies born prematurely and to assess motor performance, the Alberta Infant Motor Scale (AIMS) was used, in addition to two qualitative questionnaires to identify and control risk factors. Descriptive statistics were used and the Wilcoxon and McNemar tests to analyze changes over time (p < 0.05). Results: through the follow-up, after the guidance to the parents, the number of babies that presented motor performance below the expected was reduced, with statistical significance. The percentiles obtained in the motor performance in the two evaluation moments indicate that there was an improvement over time (p = 0.05), as well as the data related to the categorization (p = 0.04). Conclusion:it is important to monitor and identify the influence of risk factors on babies so that interventional measures can be implemented early, and the model based on guidelines is a low-cost and easily applicable method in public health services.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Infant, Premature , Child , Child Development , Risk Factors , Follow-Up Studies , Healthcare Models
10.
Rev. Méd. Inst. Mex. Seguro Soc ; 60(2): 201-210, abr. 2022. ilus, tab
Article in Spanish | LILACS | ID: biblio-1367344

ABSTRACT

El manejo del asma grave descontrolada con biológicos es un área de extrema dificultad, dada la escasez de información respecto a los criterios de inicio de los mismos, las variables a evaluar para determinar la eficacia y seguridad de su manejo, los puntos de corte para determinar el momento oportuno para cambiar o agregar otro biológico y el proceso para disminuir o retirar los esteroides. Esta revisión incorpora la información más reciente y realiza una propuesta con base en ella.


The management of severe uncontrolled asthma with biologics is an area of extreme difficulty given the scarcity of information regarding their starting criteria, the variables to be evaluated to determine the efficacy and safety of their management, the cut-off points to determine the timing to change or add another biological and the process to decrease or withdraw steroids. This review incorporates the latest information and makes a proposal based on it


Subject(s)
Humans , Male , Female , Asthma/drug therapy , Biological Therapy , Asthma/immunology , Biomarkers/blood , Follow-Up Studies , Treatment Outcome , Adrenal Cortex Hormones/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use
11.
Rev. Méd. Inst. Mex. Seguro Soc ; 60(2): 107-115, abr. 2022. tab
Article in Spanish | LILACS | ID: biblio-1367226

ABSTRACT

Introducción: el costo económico del tratamiento de cáncer de mama (CM) y el aumento en su incidencia y prevalencia desafía la estabilidad financiera de cualquier sistema de salud. Objetivo: determinar los costos médicos directos (CMD) del tratamiento de CM y los factores asociados a estos costos. Material y métodos: evaluación económica parcial en una cohorte retrospectiva de 160 pacientes con diagnóstico conf irmado de CM. Se consideraron CMD desde la perspectiva del IMSS. Se utilizó análisis de bootstrapping para tratar incertidumbre y el modelo lineal generalizado para identificar factores asociados a costos. Resultados: el costo promedio anual (CPA) del tratamiento de CM fue de $ 251,018 pesos. En estadio 1, $ 116,123; estadio II, $ 242,132; estadio III, $ 287,946, y estadio IV, $ 358,792 pesos. El CPA fue mayor en progresión del CM ($ 380,117 frente a no progresión $ 172,897), y en pacientes que fallecieron durante el seguimiento ($ 357,579) frente a aquellas que sobrevivieron ($ 218,699). Conclusiones: el CPA del tratamiento de CM fue de $ 251,018 pesos. Los CMD aumentan significativamente conforme las pacientes presentan estadios más avanzados de la enfermedad. Los factores asociados al CMD fueron edad, estadios II, III y la progresión del CM.


Background: The economic cost of breast cancer (BC) treatment and the increase in incidence and prevalence challenges the financial stability of any healthcare system. Objective: To determine direct medical costs (DMC) of BC treatment and factors associated with DMC. Material and methods: Partial economic evaluation in a retrospective cohort of 160 patients with a confirmed diagnosis of BC. DMC was considered from the IMSS perspective. Bootstrapping analysis was used to deal with uncertainty and generalized linear model to identify factors associated with DCM Results: The total average annual cost of BC treatment was $251,018 mexican pesos. In clinical stage I was $116,123, stage II $242,132, stage III $287,946, and stage IV $358,792 pesos. In progression disease, DMC were more elevate ($380,117) vs. without progression ($172,897), (p < 0.0001). In patients who died, DMC were $357,579 mexican pesos compared to those who survived ($218,699) (p < 0.0001). Conclusions: The average annual cost of CM treatment was $251,018 pesos. DMCs increase significantly as patients present more advanced stages of the disease. Factors associated with costs were age, stages II, III and the progression of BC.


Subject(s)
Humans , Female , Adult , Middle Aged , Tertiary Healthcare/economics , Breast Neoplasms/therapy , Costs and Cost Analysis , Social Security/economics , Breast Neoplasms/economics , Retrospective Studies , Follow-Up Studies , Cost-Benefit Analysis , Cost of Illness , Mexico , Neoplasm Staging/economics
12.
Rev. chil. enferm. respir ; 38(1): 20-25, mar. 2022. ilus, tab
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1388168

ABSTRACT

INTRODUCCIÓN: Las Vasculitis Asociadas a Anticuerpos Anticitoplasma de Neutrófilos (VAA) son infrecuentes, pero de amplio espectro de presentación. Si bien el consenso de clasificación de Chapel Hill del año 2012, sigue vigente, la tendencia actual es clasificarlas de acuerdo al marcador inmunológico: anti-Proteinasa 3 (PR3) o anti-mieloperoxidasa (MPO). Las manifestaciones pulmonares clásicas son la hemorragia alveolar y los nódulos pulmonares. En los últimos 10 años se ha descrito la enfermedad pulmonar difusa (EPD). Los estudios epidemiológicos son escasos, y suelen representar en su mayoría poblaciones norteamericanas o europeas. El objetivo es describir las características del compromiso pulmonar al debut en VAA en un centro universitario. PACIENTES Y MÉTODO: De un total de 190 pacientes con diagnóstico de VAA se incluyeron 170 en seguimiento en nuestro centro. Se revisaron aspectos clínicos, demográficos, laboratorio e imagenológicos de los pacientes incluidos. RESULTADOS: De los 170 pacientes, 112 (65,88%) presentaron compromiso pulmonar. 106 (94,64%) de los pacientes fueron anticuerpos anti citoplasma de neutrófilos (ANCA) positivos; de estos, 56 (53,27%) MPO (+) y 39 (36,45%) PR-3 (+). Un tercio de los pacientes de ambos grupos presentó hemorragia alveolar. En los pacientes MPO (+) predomina la EPD (53,5%) y en PR-3 (+) los nódulos pulmonares (69,23%). Destaca la baja frecuencia de patología obstructiva asociada. CONCLUSIONES: El compromiso pulmonar en las VAA es prevalente y heterogéneo. En nuestra serie, destaca la frecuencia de EPD en VAA MPO (+), lo que releva la importancia del estudio con ANCA en paciente con diagnóstico y seguimiento por EPD.


INTRODUCTION: Antineutrophil Cytoplasmic Antibodies (ANCA) associated vasculitis (AAV) are uncommon, but of broad spectrum of presentation. Although the 2012 Chapel Hill classification consensus remains valid, the current trend is to classify them according to the immunological marker: anti-Proteinase 3 antibody (PR-3) or anti-Myeloperoxidase antibody (MPO). The classic pulmonary manifestations are alveolar hemorrhage and pulmonary nodules. Interstitial lung disease (ILD) has been described in the last 10 years. Epidemiological studies are scarce, and they usually represent mostly North American or European populations. The objective is to describe the characteristics of lung involvement upon debut in AAV in a university center. PATIENTS AND METHODS: Of a total of 190 patients diagnosed with AAV, 170 were included in follow-up at our center. Clinical, demographic, laboratory and imaging aspects of the included patients were reviewed. RESULTS: Of the 170 patients, 112 (65.88%) had lung involvement. 106 (94.64%) of the patients were ANCA (+); of these, 56 (53.27%) MPO (+) and 39 (36.45%) PR-3 (+). One third of the patients in both groups had alveolar hemorrhage. In MPO (+) patients, ILD predominates (53.5%) and in PR-3 (+) pulmonary nodules (69.23%). The low frequency of associated obstructive pathology stands out. CONCLUSIONS: Pulmonary manifestations in AAVs are frequent and heterogeneous. Locally, the association of ILD and AAV MPO (+) stands out, which highlights the importance of ANCA study in patients with diagnosis and follow-up by ILD.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Lung Diseases, Interstitial/diagnosis , Lung Diseases, Interstitial/etiology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Biomarkers/analysis , Retrospective Studies , Follow-Up Studies , Lung Diseases, Interstitial/epidemiology , Lung Diseases, Interstitial/diagnostic imaging , Antibodies, Antineutrophil Cytoplasmic , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/classification , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/epidemiology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnostic imaging , Inflammation/etiology , Antibodies/analysis
13.
Int. j. cardiovasc. sci. (Impr.) ; 35(2): 174-180, Mar.-Apr. 2022. tab, graf
Article in English | LILACS | ID: biblio-1364980

ABSTRACT

Abstract Background The wide range of clinical presentations of acute coronary syndrome (ACS) makes it indispensible to use tools for risk stratification and for appropriate risks management; thus, the use of prognosis scores is recommended in the immediat clinical decision-making. Objective To validate the Global Registry of Acute Coronary Events (GRACE) score as a predictor of in-hospital and 6-month post-discharge mortality in a population diagnosed with ACS. Methods This is a prospective cohort study of consecutive patients diagnosed with ACS between May and December 2018. GRACE scores were calculated, as well as their predictive value for in-hospital and 6-month post-discharge mortality. The validity of the model was assessed by two techniques: discriminative power using the area under the receiver operating characteristic curve (AUC) and goodness-of-fit, using the Hosmer-Lemeshow (HL) test, at the 5% level of significance. Results A total of 160 patients were included, mean age 64 (±10.9) years; of which 60% were men. The risk model showed to have satisfactory ability to predict both in-hospital mortality, with an area under the curve (AUC) of 0.76 (95% confidence interval [CI], 0.57-0.95; p = 0.014), and 6-month post-discharge mortality, with AUC of 0.78 (95%CI, 0.62-0.94), p = 0.002. The HL test indicated good-fit for both models of the GRACE score. Conclusion In this study, the GRACE risk score for predicting mortality was appropriately validated in patients with ACS, with good discriminative power and goodness-of-fit. The results suggest that the GRACE score is appropriate for clinical use in our setting.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Risk Assessment/methods , Acute Coronary Syndrome/mortality , Prognosis , Predictive Value of Tests , Prospective Studies , Risk Factors , ROC Curve , Follow-Up Studies , Hospital Mortality , Acute Coronary Syndrome/diagnosis
14.
Int. j. cardiovasc. sci. (Impr.) ; 35(2): 202-213, Mar.-Apr. 2022. tab, graf
Article in English | LILACS | ID: biblio-1364977

ABSTRACT

Abstract Background Short message service (SMS) to promote healthcare improves the control of cardiovascular risk factors, but there is a lack of evidence in low and middle-income countries, particularly after acute coronary syndromes (ACS). Objective This study aims to evaluate whether the use of SMS increases risk factor control after hospital discharge for ACS. Methods IMPACS is a 2-arm randomized trial with 180 patients hospitalized due to ACS at a tertiary hospital in Brazil. Eligible patients were randomized (1:1) to an SMS intervention (G1) or standard care (G2) upon hospital discharge. The primary endpoint was set to achieve 4 or 5 points in a risk factor control score, consisting of a cluster of 5 modifiable risk factors: LDL-C <70mg/dL, blood pressure (BP) <140/90mmHg, regular exercise (≥5 days/week, 30 minutes/session), nonsmoker status, and body mass index (BMI) <25 kg/m2] at 6 months. Secondary outcomes were components of the primary outcome plus rehospitalization, cardiovascular death, and death from any cause. Results are designated as significant if p<0.05. Results From randomized patients, 147 were included in the final analysis. Mean age was 58 (51-64) years, 74% males. The primary outcome was achieved by 12 (16.2%) patients in G1 and 15 (20.8%) in G2 (OR=0.73, 95%CI 0.32-1.70, p=0.47). Secondary outcomes were also similar: LDL-C<70 mg/dl (p=0.33), BP<140/90 mmHg (p=0.32), non-smoker (p=0.74), regular exercise (p=0.97), BMI (p=0.71), and rehospitalization (p=0.06). Death from any cause occurred in three participants (2%), including one cardiovascular death in each group. Conclusion SMS intervention did not significantly improve cardiovascular risk factor control when compared to standard care in patients discharged after ACS in Brazil.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Acute Coronary Syndrome/prevention & control , Secondary Prevention/methods , Text Messaging , Patient Discharge , Double-Blind Method , Follow-Up Studies , Longitudinal Studies , Telemedicine/methods , Heart Disease Risk Factors , Health Promotion/methods
15.
Rev. méd. Chile ; 150(2): 178-182, feb. 2022. ilus, tab
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1389641

ABSTRACT

BACKGROUND: The presence of a chronic total occlusion (CTO) in a non-infarct-related artery in patients with acute myocardial infarction (AMI), may be a sign of bad prognosis. AIM: To estimate the long-term survival of patients with AMI who were studied with coronarography during 2013-2014 who had one or more CTO in a non-infarct-related artery. MATERIAL AND METHODS: Review of coronary angiograms performed between 2013 and 2014 to patients with an AMI. Patients were grouped as having or not a CTO in a non-infarct-related artery. Their medical records were reviewed, and mortality was determined requesting their death certificates. RESULTS: Of 993 patients with AMI under-going coronarography, 233 (23.5%) had at least one CTO. Patients with CTO were older (66 and 62 years respectively). They also had a higher prevalence of hypertension, diabetes mellitus (DM), kidney failure and moderate to severe systolic ventricular dysfunction. The independent predictors of mortality were CTO, age, DM and kidney failure. Survival at an average follow-up period of 57 months was significantly higher in patients without CTO (89.5 and 80.3% respectively, p < 0.01). CONCLUSIONS: The presence of CTO in patients with acute myocardial infarction is associated with a higher frequency of cardiovascular risk factors and lower long-term survival.


Subject(s)
Humans , Renal Insufficiency/etiology , Coronary Occlusion/complications , Coronary Occlusion/diagnostic imaging , Percutaneous Coronary Intervention/adverse effects , Myocardial Infarction/diagnostic imaging , Prognosis , Chronic Disease , Risk Factors , Follow-Up Studies , Treatment Outcome
16.
Rev. Assoc. Med. Bras. (1992) ; 68(2): 183-190, Feb. 2022. tab
Article in English | LILACS | ID: biblio-1365348

ABSTRACT

SUMMARY OBJECTIVE: The aim of this study was to ascertain the long-term respiratory effects of COVID-19 pneumonia through pulmonary function tests in follow-ups at 1 and 6 months. METHODS: Our study was conducted between August 1, 2020 and April 30, 2021. At 1 month after discharge, follow-up evaluations, PFTs, and lung imaging were performed on patients aged above 18 years who had been diagnosed with COVID-19 pneumonia. In the 6th month, the PFTs were repeated for those with pulmonary dysfunction. RESULTS: A total of 219 patients (mean age, 49±11.9 years) were included. Pathological PFT results were noted in the 1st month for 80 patients and in the 6th month for 46 (7 had obstructive disorder, 15 had restrictive disorder, and 28 had small airway obstruction) patients. A significant difference was found between abnormal PFT results and patient-described dyspnea in the 1st month of follow-up. The 6-month PFT values (especially those for forced vital capacity) were statistically significantly lower in the patients for whom imaging did not indicate complete radiological improvement at the 1-month follow-up. No statistically significant difference was found between the severity of the first computed tomography findings or clinical condition on emergency admission and pulmonary dysfunction (Pearson's chi-square test, P=0.904; Fisher's exact test, P=0.727). CONCLUSION: It is important that patients with COVID-19 pneumonia be followed up for at least 1 month after discharge to be monitored for potential long-term lung damage. PFTs should be administered to those in whom ongoing dyspnea, which started with COVID-19, and/or full recovery were not identified in pulmonary imaging.


Subject(s)
Humans , Adult , Aged , COVID-19 , Respiratory Function Tests , Vital Capacity , Follow-Up Studies , SARS-CoV-2 , Lung/diagnostic imaging , Middle Aged
17.
J. pediatr. (Rio J.) ; 98(1): 60-68, Jan.-Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1360552

ABSTRACT

Abstract Objective: This longitudinal study aimed to verify possible changes in the time spent in sedentary activities occurring as screen-time, educational, cultural, social, and transportation domains in a sample of Brazilian adolescents between 2015 and 2017. Methods: It is a longitudinal prospective study with 586 adolescents from 12 to 15 years old at the Baseline (2015) enrolled in 14 public schools from Curitiba, Brazil. The Adolescent Sedentary Activity Questionnaire assessed the time spent in sedentary activities in five domains (recreational screen-time, educational, cultural, social, and transportation). A series of linear random effects regressions analyzed changes in the sedentary time between 2015 and 2017, with p < .05. Results: Overall, 323 adolescents dropped out of the study resulting in a retention rate of 44.9%. The overall sedentary time remained stable from 2015 to 2017 (-3.98 min/day, 95%CI: -15.39; 7.42). The screen-time decreased (-22.22 min/day, 95%CI: -30.30; -14.15), and educational (8.29 min/day, 95% CI: 3.52; 13.06), cultural (3.41 min/day, 95% CI: 0.66; 6.15) and social sedentary activities (8.20 min/day, 95% CI: 2.06; 14.34) increased from 2015 to 2017. Conclusion: Significant reductions in screen-time were evidenced along with increases in time spent on other sedentary activities of educational, cultural, and social nature.


Subject(s)
Humans , Child , Adolescent , Sedentary Behavior , Screen Time , Prospective Studies , Follow-Up Studies , Longitudinal Studies
18.
Arch. argent. pediatr ; 120(1): S9-S18, feb 2022. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1353852

ABSTRACT

La hipertensión portal es un síndrome complejo producido por un aumento de la resistencia al flujo venoso esplácnico a nivel de la vena porta o sus ramas, con una circulación sistémica hiperdinámica caracterizada por vasodilatación periférica y aumento del gasto cardíaco. El sitio de obstrucción al flujo portal puede ser prehepático (hígado normal), intrahepático (como en la cirrosis) o posthepático (síndrome de BuddChiari). En los pacientes pediátricos, las causas prehepáticas e intrahepáticas se reparten en proporciones casi iguales (aproximadamente el 50 % cada una). La expresión clínica y el impacto individual son muy variados, pero en todos los casos expresan un deterioro en la salud de los pacientes y la necesidad de corregir el problema, tanto en sus consecuencias como, idealmente, en sus causas.


Portal hypertension is a complex syndrome caused by increased resistance to the splachnic venous flow at the portal vein level, with a hyperdynamic systemic circulation characterized by peripheral vasodilation and high cardiac output. Portal flow can be obstructed at prehepatic (¨normal liver¨), intrahepatic (as in cirrhosis), or post-hepatic level (as in Budd-Chiari syndrome). In pediatric patients, prehepatic and intrahepatic causes are almost equally distributed (nearly 50% each). Clinical presentation and individual impact are heterogeneous, but in each case, it is the expression of a worsening condition and the need to solve the problem, either by treating its consequences or (ideally) its causes.


Subject(s)
Humans , Child , Adolescent , Hypertension, Portal/diagnosis , Hypertension, Portal/etiology , Hypertension, Portal/drug therapy , Portal Vein , Vasodilation , Follow-Up Studies , Liver Cirrhosis/complications
19.
Arch. argent. pediatr ; 120(1): S19-S61, feb 2022. tab
Article in Spanish | LILACS, BINACIS | ID: biblio-1353860

ABSTRACT

La historia natural de la enfermedad hepática crónica (EHC) se caracteriza por una fase de cirrosis compensada asintomática seguida de una fase descompensada, que se acompaña de signos clínicos evidentes, de los cuales los más frecuentes son la ascitis, las hemorragias, la encefalopatía y la ictericia. Esta guía actualizada sobre el manejo de pacientes con EHC en la edad pediátrica fue confeccionada con el propósito de mejorar la práctica clínica de estos pacientes complejos y darle herramientas al pediatra de cabecera para un seguimiento adecuado. Para ello, un grupo de expertos subrayó la importancia del inicio temprano del tratamiento etiológico en cualquier grado de enfermedad hepática y ampliaron su labor jerarquizando las complicaciones de la cirrosis: ascitis, hemorragia digestiva, infecciones, malnutrición; aspectos endocrinológicos, neurológicos, oftalmológicos y gastrointestinales; y complicaciones vasculares pulmonares y renales. Se incluyeron, además, aspectos psicosociales, así como el cuidado del adolescente en su transición a la vida adulta.


The natural history of chronic liver disease (CLD) is characterized by a phase of asymptomatic compensated cirrhosis followed by a decompensated phase, accompanied by the development of evident clinical signs, the most frequent being ascites, hemorrhages, encephalopathy and jaundice. This updated guideline on the management of pediatric patients with CLD was developed with the purpose of improving the clinical practice of these complex patients and to provide the pediatrician with tools for an adequate follow-up. To this end, a group of experts, after stressing the importance of early initiation of etiologic treatment in any degree of liver disease, expanded their work to include a hierarchy of complications of cirrhosis: ascites, gastrointestinal bleeding, infections, malnutrition, endocrinological, neurological, ophthalmological, gastrointestinal, pulmonary vascular and renal complications. Psychosocial aspects including the care of the adolescent in their transition to adult life were also included.


Subject(s)
Humans , Child , Adolescent , Adult , Ascites/etiology , Jaundice , Follow-Up Studies , Gastrointestinal Hemorrhage/etiology , Liver Cirrhosis/therapy
20.
Säo Paulo med. j ; 140(2): 188-198, Jan.-Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1366047

ABSTRACT

Abstract BACKGROUND: Among women who have suffered loss of pregnancy, the level of grief decreases gradually. Age, mental health status and childlessness are the factors known to mostly affect women's levels of grief. OBJECTIVES: To assess the levels of grief among women who experienced perinatal loss and the changes in their ruminative thought styles over the first year after their loss. DESIGN AND SETTING: One-year follow-up study carried out in a university hospital in Turkey. METHODS: The study population included 70 women who experienced loss of pregnancy in the hospital. The sample size was calculated using G*Power V3.1. Data were collected at 48 hours, at the third month, at the sixth month and at one year after pregnancy loss, between June 2018 and June 2019. A personal information form, the Perinatal Grief Scale and the Ruminative Thought Style Questionnaire were used for data collection. RESULTS: The women's highest levels of grief and ruminative thought style were in the first 48 hours. Their tendency towards grief and ruminative thought styles decreased over the repeated measurements during the follow-up. Women aged 20-29 years had the highest levels of grief at the third month after perinatal loss. CONCLUSIONS: Nursing assessments regarding grief and ruminative thought style over the first 48 hours after perinatal loss should be integrated into nursing care for these women. Grief follow-up programs for these women can be developed through nursing research.


Subject(s)
Humans , Female , Pregnancy , Adult , Young Adult , Grief , Abortion, Spontaneous , Turkey , Cohort Studies , Follow-Up Studies
SELECTION OF CITATIONS
SEARCH DETAIL